Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers.

Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, Zanette M, Littera R, Carcassi C, Sotgiu S, Clerici M.

Brain Behav Immun. 2014 Feb;36:54-60. doi: 10.1016/j.bbi.2013.10.006. Epub 2013 Oct 11.

PMID:
24120931
2.

Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.

Torres AR, Westover JB, Gibbons C, Johnson RC, Ward DC.

Brain Behav Immun. 2012 Oct;26(7):1122-7. doi: 10.1016/j.bbi.2012.07.014. Epub 2012 Aug 3.

3.

Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.

Kitpoka P, Tammakorn C, Chaisri S, Leelayuwat C, Mongkolsuk T, Thammanichanond D.

Hum Immunol. 2016 Jun;77(6):470-5. doi: 10.1016/j.humimm.2016.04.019. Epub 2016 Apr 27.

PMID:
27131859
4.

An HLA-G(∗)14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders.

Guerini FR, Bolognesi E, Chiappedi M, Ghezzo A, Canevini MP, Mensi MM, Vignoli A, Agliardi C, Zanette M, Clerici M.

Brain Behav Immun. 2015 Feb;44:207-12. doi: 10.1016/j.bbi.2014.10.002. Epub 2014 Oct 18.

PMID:
25451607
5.

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.

Int J Immunogenet. 2010 Jun;37(3):159-68. doi: 10.1111/j.1744-313X.2010.00906.x. Epub 2010 Feb 24.

PMID:
20193031
6.

Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Du Z, Gjertson DW, Reed EF, Rajalingam R.

Immunogenetics. 2007 Jan;59(1):1-15. Epub 2006 Nov 14.

PMID:
17103212
7.

The distribution of KIR-HLA functional blocks is different from north to south of Italy.

Fasano ME, Rendine S, Pasi A, Bontadini A, Cosentini E, Carcassi C, Capittini C, Cornacchini G, Espadas de Arias A, Garbarino L, Carella G, Mariotti ML, Mele L, Miotti V, Moscetti A, Nesci S, Ozzella G, Piancatelli D, Porfirio B, Riva MR, Romeo G, Tagliaferri C, Lombardo C, Testi M, Amoroso A, Martinetti M.

Tissue Antigens. 2014 Mar;83(3):168-73. doi: 10.1111/tan.12299.

PMID:
24571475
8.

KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Augusto DG, Petzl-Erler ML.

Hum Genet. 2015 Sep;134(9):929-40. doi: 10.1007/s00439-015-1579-9. Epub 2015 Jun 23. Review.

PMID:
26099314
9.

Distribution of KIR genes in the Croatian population.

Burek MK, Grubic Z, Stingl K, Zunec R.

Hum Immunol. 2013 Aug;74(8):952-6. doi: 10.1016/j.humimm.2013.04.028. Epub 2013 Apr 28.

PMID:
23632062
10.

KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity.

Terszowski G, Klein C, Stern M.

J Immunol. 2014 Jun 15;192(12):5618-24. doi: 10.4049/jimmunol.1400288. Epub 2014 May 2.

11.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.

12.

Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.

Mahmoudi M, Jamshidi AR, Karami J, Mohseni A, Amirzargar AA, Farhadi E, Ahmadzadeh N, Nicknam MH.

Iran J Allergy Asthma Immunol. 2016 Feb;15(1):27-38.

13.

KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.

Portela P, Merzoni J, Lindenau JD, Damin DC, Wilson TJ, Roesler R, Schwartsmann G, Jobim LF, Jobim M.

Hum Immunol. 2017 Mar;78(3):263-268. doi: 10.1016/j.humimm.2017.01.003. Epub 2017 Jan 11.

PMID:
28088355
14.

KIR genes and HLA class I ligands in Gaucher disease.

Vairo F, Portela P, Salim PH, Jobim M, Netto C, Dorneles A, Mittlestadt S, Jobim LF, Schwartz IV.

Gene. 2013 Mar 1;516(1):53-7. doi: 10.1016/j.gene.2012.12.014. Epub 2012 Dec 21.

15.

HLA and KIR polymorphisms affect NK-cell anti-tumor activity.

Passweg JR, Huard B, Tiercy JM, Roosnek E.

Trends Immunol. 2007 Oct;28(10):437-41. Epub 2007 Sep 7.

PMID:
17825623
16.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.

Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.

Biol Blood Marrow Transplant. 2010 Feb;16(2):273-80. doi: 10.1016/j.bbmt.2009.10.021. Epub 2009 Oct 24.

17.

Overview of the killer cell immunoglobulin-like receptor system.

Rajalingam R.

Methods Mol Biol. 2012;882:391-414. doi: 10.1007/978-1-61779-842-9_23. Review.

PMID:
22665247
18.

How Does the maternal immune system contribute to the development of pre-eclampsia?

Moffett A, Hiby SE.

Placenta. 2007 Apr;28 Suppl A:S51-6. Epub 2007 Feb 8.

PMID:
17292469
19.

Distribution of killer cell immunoglobulin-like receptor genes and combinations with HLA-C ligands in an isolated Han population in southwest China.

Shi L, Shi L, Tao Y, Lin K, Liu S, Yu L, Yang Z, Yi W, Huang X, Sun H, Chu J, Yao Y.

Tissue Antigens. 2011 Jul;78(1):60-4. doi: 10.1111/j.1399-0039.2011.01683.x. Epub 2011 May 4.

PMID:
21542807
20.

The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.

Valentin N, Gagne K, Kerdudou N, Hallé L, Kaplan C, Killie MK, Skogen B, Muller JY, Bignon JD.

Transfusion. 2007 Dec;47(12):2322-9. Epub 2007 Aug 21.

PMID:
17714418

Supplemental Content

Support Center